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MEDICATION-RELATED PROBLEMS EXPERIENCED BY PATIENTS DURING 
TRANSITIONS TO ASSISTED LIVING 
 
 
By Deanna Stephanie Flora, Pharm.D., M.S. 
 
 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of 
Science at Virginia Commonwealth University. 
 
 
Virginia Commonwealth University, 2012 
 
 
Major Director:  Patricia W. Slattum, Pharm.D., Ph.D. 
Associate Professor and Geriatric Pharmacotherapy Program Director 
Department of Pharmacotherapy and Outcomes Science 
 
 
Medication reconciliation is a systematic and comprehensive review of 
medication regimens during care transitions aiming to prevent adverse drug events.  
Poorly executed transitions negatively impact patient welfare and cause financial 
burden.  Medication-related problems (MRPs) experienced during transitions to an 
assisted living facility (ALF) were evaluated.   
Data was collected from pharmacy records for transitions to an ALF over three 
months, including demographics, medications, potentially inappropriate medications, 
and MRPs.  MRPs were categorized and summarized using descriptive statistics. 
 Forty-five patients (71% female) experienced 59 transitions.  Average age was 
85.6 years.  Median length of stay away from the ALF was three days.  There were 
averages of 18.3 pre-transition medications, 12.5 medications in the discharge orders 
and/or upon ALF admission, and 15.9 final medications.  979 MRPs were identified, 
mostly no indication documented, followed by underuse, overuse, and non-adherence.   
Many of the identified MRPs are potentially preventable.  Interventions are 
needed to reduce MRPs during ALF transitions.  
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CHAPTER 1 
Background 
 
 
Older adults commonly experience transitions in care within health care settings 
and between health care settings.  The types of care transitions, barriers to effective 
transitions, assessments of transitions, and recommendations for improving transitions 
are discussed.  The assisted living setting is one setting involved in care transitions of 
older adults.  Less focus has been placed on studying this setting, most likely due to the 
variations in regulations between states and difficulty in obtaining data for research in 
this setting.  Assisted living facilities are defined and the Virginia regulations are 
discussed, along with demographic information.  Patients are prone to medication-
related problems during care transitions; therefore, the classification and effect of 
medication-related problems are reviewed.  Pharmaceutical care and medication 
reconciliation are discussed as ways to address medication-related problems.  Studies 
from the literature are reviewed as well as the gaps in the literature regarding 
medication-related problems during transitions involving the assisted living setting. 
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I.  Transitions 
 
a.  Types 
Transitional care has been defined as a set of actions with the purpose of 
ensuring the coordination and continuity of care as patients experience transitions.1  
Care transitions may occur within a health care setting or between different health care 
settings.  For example, patients may transition between units in the hospital as their 
condition changes.  Additionally, transitions in care may include admission or discharge 
from a hospital and transfers to long-term care (LTC) or home care.  Care transitions 
are common occurrences in the lives of older adults with both acute and chronic 
conditions, and involve the patients, caregivers, physicians, nurses, pharmacists, social 
workers, and other health care professionals.2 
Transitions in care are very common in LTC settings, which include assisted 
living facilities, nursing homes, skilled nursing facilities, and hospice care.  LTC settings 
provide comprehensive, longitudinal, patient-centered services, including formal and 
informal health and support services.1  Within the LTC environment, transitions include 
transfers from home, emergency departments, and hospital settings. 
The importance of care transitions are illustrated by the fact that more than 25% 
of nursing home residents receive care from an emergency department each year.1  
Patients are often admitted to the hospital for acute care and/or LTC settings for post-
acute care.  It has been noted that almost 5 million patients over 65 years of age 
experienced more than 15 million transitions during a two year period.1  After discharge 
to the community, over 1.1 million of these patients experienced subsequent health care 
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use in hospital, emergency department, and institutional settings.1  Prevalent issues 
with transitional care are suggested by the frequent subsequent use of health care in 
the older adult population, some of which is potentially preventable. 
Ideally, transitions should involve a comprehensive care plan involving health 
care professionals who are available, experienced, and have access to relevant medical 
information.1  A person-centered approach should be employed that takes into account 
the patient’s goals, preferences, and clinical status.1   
 
b.  Barriers 
The literature regarding care transitions for older adults primarily focuses on 
barrier identification or problems leading to patient risk and lack of safety.3  However, 
there are many challenges to improving the quality of transitional care.  Barriers to 
effective care transitions occur at three levels:  the delivery system, the clinician, and 
the patient.4  Institutions often function in isolation despite the fact that collaboration 
across health care institutions is central to effective care transitions.5  Additionally, 
access to an electronic health information system is not available in all health delivery 
systems and available systems do not communicate with each other.5  
Barriers for interprofessional teams involve communication gaps and lack of 
timely information.3  Even when collaboration occurs, inaccurate or incomplete 
communication can result in medication discrepancies.  These discrepancies include 
discontinuation of use; dose changes in existing medications caused by adverse drug 
events; drug omission; incorrect drug; prescribing errors; dispensing errors; 
unintentional non-adherence; incomplete, inaccurate, or illegible discharge instructions; 
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and duplicate therapy.6  Underuse, misuse, and overuse of medications are problems 
that need to be addressed.   
Medication errors, noncompliance issues, nursing home placement, increased 
caregiver burden, and increased health care costs have been identified as markers of 
poor transitions.7  Poorly executed transitions in care may result in fragmentation of 
care, poor clinical outcomes, inappropriate use of emergency department services, and 
hospital readmission.8  Improper transitions in care can lead to adverse events for 
patients.9  Transitions at shift changes may cause a perpetuation of issues such as a 
failure to accurately diagnose an underlying medical illness as is illustrated in a case 
scenario by Beach et al.10  Discontinuity of care may threaten the patient’s safety and 
quality of patient care.10   
 
c.  Assessments 
Assessment tools are instrumental in measuring the quality of transitional care.  
Coleman et al. designed and tested the Care Transition Measure (CTM) as a patient-
centered measure of the quality of care delivered to older adults receiving care across 
multiple settings.11  Participants included older adults recently discharged from the 
hospital that received subsequent care at a skilled nursing facility or home setting.11  
Coleman et al. identified four domains from focus group data including information 
transfer; patient and caregiver preparation; support for self-management; and 
empowerment to assert preferences.11  The full 15-item CTM contains three items that 
focus on medications, specifically on understanding the purpose for taking each 
medication, how to take each medication (including how much to take and when), and 
5 
 
the possible side effects of each medication.12  The CTM was found to be highly 
relevant and comprehensive and may be a useful health system performance 
evaluation tool.11  The CTM has also been shown to perform in a more diverse 
population of a national sample of African American, Hispanic American, and rural-
dwelling individuals aged 18 to 90 years.12  Parry et al. found that the 3-item CTM 
accurately predicts the score on the full 15-item CTM, which may lead to lower cost and 
response burden.12  Additionally, Shadmi et al. assessed the validity and reliability of the 
Hebrew and Arabic translations of the CTM.13  The Hebrew and Arabic translations of 
the questionnaire were found to be reliable and valid for the assessment of patients’ 
transitions between hospital and community care.13  The CTM is also a valid and 
reliable measure for evaluating care transition quality in Singapore.14 
Hallmarks of successful care interventions have been identified by Sims-Gould et 
al. based on semi-structured interviews.3  These hallmarks include a focus on 
information gathering and communication in addition to patient autonomy and care 
pathways (physical and medical benchmarks).3  Future attempts to improve transitions 
in care should focus on these hallmarks.  Formal feedback loops for sharing information 
and letting go of rigid care pathways may be two approaches for breaking barriers.3 
 
d.  Recommendations 
Recommendations have emerged from studies focusing on approaches to 
improving transitions in care.  The Transitional Care Model (TCM), a team-based care 
delivery system led by a nurse, was developed to improve care transitions.15  The aim of 
the TCM is to align the care system with the needs, preferences, and values of the 
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patient and caregiver in order to obtain improved outcomes and lower costs.15  The 
TCM includes comprehensive discharge planning and follow-up care at home for 
chronically ill, high-risk, older adults.15  It focuses on the patient and caregiver in terms 
of managing symptoms, educating and promoting self-management, collaborating, 
assuring continuity, coordinating care, maintaining relationships, screening, and 
engaging elder and caregiver.15  The TCM targets older adults with two or more risk 
factors, such as a history of recent hospitalizations, multiple chronic conditions or 
medications, and poor self-health ratings.15  Key components of the TCM are the 
transitional care nurse; an evidence-based plan of care; home visits; continuity of care 
between physicians and follow-up visits from both the transitional care nurse and 
physician; focus on each patient’s needs; active engagement; early identification and 
response to risks; multidisciplinary approach; physician-nurse collaboration; and 
communication between the patient, caregivers, and health care providers.15,16  The 
TCM has resulted in a reduction in preventable hospitalizations, improved health 
outcomes, enhanced patient satisfaction, and a decrease in total health care costs.15 
It is also important to recognize barriers and facilitators impacting the TCM.  
Naylor lists several barriers to implementation of the TCM including legal, regulatory, 
and administrative; organizational culture and standard operating procedures; 
enrollment and marketing of innovation; patient and provider needs and expectations; 
defining roles of staff; and information technology needs.15  Facilitators of the TCM 
include strong champions; good fit for the organization; all involved and fully engaged 
from start to finish; flexibility; awareness of external climate; marketing plan; and 
milestones and success measures.15   
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A large health plan integrated the TCM and found health status and quality of life 
improvements; specifically, there was a decrease in re-hospitalizations and total 
hospital days.16  Also of note is a cost savings was found with the implementation of the 
TCM.16   
Hospital readmissions have also been successfully reduced with a Transitions of 
Care Program that was implemented based on the Transitional Care Model.17  The 
Transitions of Care Program utilized home care nurses educated in transitional care that 
provided intensive education and follow-up for Medicare patients with chronic diseases 
and a high risk of readmission.17 
A checklist was developed of processes and elements required for optimal 
discharge, which was completed by researchers, process improvement experts, and 
hospitalists and endorsed by the Society of Hospital Medicine.9  Medication safety, 
patient education, and follow-up plans are the focus of the checklist.9  The final list 
contains the following data elements:  the presenting problem that precipitated 
hospitalization; key findings and test results; final primary and secondary diagnoses; 
brief hospital course; condition at discharge; discharge destination; discharge 
medications with a written schedule, purpose, cautions, and comparison with 
preadmission medications; follow-up appointments with provider’s name, date, address, 
phone number, purpose, and suggested management plan; all pending labs or tests 
and to whom results should be sent; recommendations from sub-specialty consultants; 
documentation of patient education and understanding; any anticipated problems and 
suggested interventions; 24/7 call-back number; identify referring and receiving 
providers; and resuscitation status and other end-of-life issues.9   
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The pharmacist’s role was studied utilizing an intervention that involved 
pharmacists, in collaboration with other health care providers, reconciling and optimizing 
medications from multiple settings of care.18  The pharmacist also provided care 
management and ongoing support for 30 days after discharge.18  The intervention led to 
a 30% reduction in readmission rates.18  Novak et al. concluded that pharmacists 
managing care transitions between sites reduces unnecessary health care utilization 
and cost, as well as provides benefits to the patient allowing the patient to remain 
healthy at home after hospitalization.18 
A study of Department of Veterans’ Affairs (VA) patients in acute care with sub-
acute needs found that there were 34% of admissions to acute care when a different 
level of care would be appropriate.19  Costs can be reduced by identifying patients with 
sub-acute needs and admitting or transferring these patients to a more appropriate and 
lower cost setting; therefore, the VA should consider developing strategies to identify 
patients with sub-acute needs.19 
The Transitional Care Center (TCC) is a partnership between a large managed 
care organization and five nursing homes and is a sub-acute program with the purpose 
of promoting continuity of care for frail older adults.20  Rehabilitation and geriatric 
evaluation are provided through the TCC partnership.20  A retrospective study found the 
TCC resulted in a lower post-acute length of stay and high patient and physician 
satisfaction.20  An economic benefit and improvements in care and utilization outcomes 
were also associated with the TCC partnership.20 
Not all studies have shown a decrease in hospitalization and costs.  An analysis 
was conducted summarizing the results of 15 randomized controlled trials of care 
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coordination programs, which involved nurse-provided patient education and monitoring 
(mostly via telephone).21  The results indicated an inability to show a significant 
difference compared to usual care with regards to hospitalizations.21  Peikes et al. also 
concluded that care coordination programs are unlikely to yield a decrease in Medicare 
expenditures, particularly without a strong transitional care component.21  It is suspected 
that the best approach would be to combine an ongoing model with proven transitional 
care models to reduce hospital readmissions.21   
Regarding emergency care transitions, Beach et al. recommend improving team 
situational awareness and communication; creating a culture that encourages joint 
accountability; exploring information technology to facilitate effective transfer of relevant 
information; and increasing awareness of hazards of transitions and techniques for 
successful knowledge transfer.10 
Parsons et al. studied emergent care transport patterns in the residential setting 
and found significant differences between independent senior apartments, licensed 
residential care, and nursing homes, as well as between facilities within these 
categories.22  The results indicated that standardization of transfer processes from one 
setting to the next are advisable.22  In addition, home health services and other 
outpatient services may be necessary.22 
Care transitions have also been studied in the field of gerontological social work.  
An intervention was studied in which social workers contacted patients transitioning 
from an acute care setting to home who were identified based on risk factors.7  A 
psychosocial assessment was conducted and a plan of care was developed over the 
phone.7  Through interviews with the social workers, themes of surprises after discharge 
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were identified as common, many of which cannot be anticipated or addressed ahead of 
time.7  Short hospital stays, compressed time frames, and difficulty anticipating 
circumstances after discharge make it difficult to prepare and educate patients and 
caregivers prior to the transition.7  Social workers also commented on their focus on 
incorporating the target client system (patient and caregiver) and action system 
(resources to help accomplish goals).7  The theme of relationship building also 
emerged.  Patients benefited most from participation in the helping relationship with the 
social worker.7  These themes highlight the importance of the role of surprises after 
discharge, expansion of the view of the client system, and development of a helping 
relationship for the success of interventions.7 
Encouraging patients and caregivers to actively engage in the patient’s care is 
important.  Coleman et al. found that encouraging community-dwelling adults admitted 
to the hospital and their caregivers to take an active role during care transitions may 
reduce rates of subsequent hospitalization.23  The patients and caregivers were 
provided tools to promote cross-site communication, encouraged to be active in their 
care and assert their preferences, and received help from a transition coach.23   
The Canadian Health Services Research Foundation published an article on 
connected care, which discussed building successful, patient-centered pathways.24  
Important elements of building successful pathways outlined in this article can be 
applied to many types of transitions.  Recommendations include seeking input on a new 
process from all stakeholders; ensuring the process has advantages for all stakeholders 
and they are aware of the advantages; and asking for stakeholder feedback on 
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improvements and visibly incorporate improvements into the process.24  The result was 
improved satisfaction for patients and caregivers.24   
Recommendations for improving transitions in care focus on communication 
between health care professionals as well as between the patient and the health care 
provider.25  Five recommendations were mentioned by Coleman and Williams regarding 
executing high-quality care transitions.25  These recommendations include greater 
recognition for the role of caregivers; define an appropriate follow-up interval; define 
physician accountability for patients who are referred to home health; delineate the role 
of the hospitalist in the advanced medical home; and develop the ability to examine 
episodes of care.25   
Given the growing older adult population, health care professionals need to have 
the education and training to meet the needs of this population.  There has been a lack 
of formal education regarding improving patient care transitions.  Tanner et al. identified 
one example of a lack in necessary knowledge.  Through focus groups and interviews, 
deficits in medical knowledge and skills to care for older adults were identified in 
academic general internists, which also leads to internists’ frustration with the process 
of delivering care to this population.26  Additionally, gaps in knowledge of guiding care 
transitions for patients and using multidisciplinary teams effectively were acknowledged; 
this also impacts effectively teaching the proper care of older adults.26  These deficits 
should be addressed through education and training in order to improve geriatric care.  
An online survey indicated that 63% of neurosurgical residents had not received formal 
instruction regarding effective handoffs (verbal and written communication during care 
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transitions).27  Education regarding effective patient care handoffs should be increased 
in training programs.27 
Several studies have focused on meeting this need for education through 
clerkships, faculty development workshops, web-based modules, and virtual 
classrooms.  To address this gap, Bray-Hall et al. developed a feasible and effective 
program to teach evidence-based transitional care.28  The program, Transition in Care 
Curriculum, consisted of interactive sessions and self-directed learning exercises and 
was found to improve medical students’ overall combined confidence in transitional care 
skills.28  The program also enabled students to identify medication discrepancies during 
43% of post-discharge visits and the most common reasons for discrepancies were 
found to be patient lack of understanding of instructions and intentional non-adherence 
to the medication plan.28   
Another attempt to close the education gap involved a mandatory geriatrics 
clerkship for third-year medical students focusing on clinical experiences in outpatient 
clinics, transitional care units, nursing homes, and hospice programs, in addition to core 
didactic sessions.29  This clerkship provided students with sufficient knowledge to 
complete the requirements satisfactorily, but results indicated that the students did not 
highly value the experience and only a few students were inspired to pursue a career in 
geriatrics.29  Powers et al. also mentioned the importance of strong leadership and 
administration’s support for the success of the program.29   
Another clerkship was implemented for pharmacy students and focused on 
transitional care.30  Pharmacy students were involved in transitional care planning for 
patients discharged from general medicine services, which included interviewing 
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patients; assessing discharge medications; reconciling medications at admission and 
discharge; providing medication counseling; and conducting follow-up via phone post-
discharge to help with MRPs and other patient concerns.30  The clerkship had an impact 
on the number of assessments and interviews of patients, as well as students’ provider-
patient and provider-provider communication skills.30  Medication adherence barriers 
were also identified and resolved as a result of the students.30  The impact of the 
clerkship was not only positive for the students, but also for the hospital and the patient 
care services provided. 
A faculty development workshop was developed to improve general internists’ 
knowledge and self-perceived competence in their care of geriatric patients and to 
increase their teaching of this population for students.31  Content discussions and small 
group role plays were developed focusing on assessment of cognition, function, and 
decisional capacity; managing care transitions; and treatment of behavioral symptoms.31  
Eckstrom et al. found that the workshop improved knowledge scores and self-perceived 
competence.31   
A 30-minute, online, case-based module was developed for medical trainees and 
students with the intent of increasing their understanding of transitional care.32  
Specifically, learners were educated on the importance of effective communication 
during the discharge process; the sources of payment for older adults in the health care 
system; and the various discharge site options.32  For fourth-year medical students, a 
virtual classroom was used to educate on care transitions and how to develop and 
implement a safe discharge plan.33  Eskildsen et al. determined that the virtual 
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classroom improved students’ confidence and knowledge regarding performing 
discharge tasks.33 
Care transitions have been researched from a number of angles.  Studies 
regarding transitions in care focus on different settings of care, barriers to effective 
transitions, methods of assessing the quality of transitions, and recommendations for 
improvement.  Barriers and recommendations may or may not apply to different health 
care settings.  It is important to understand each setting and setting-specific challenges 
in order to develop an approach to improving care transitions.  
 
 
II.  Assisted Living 
 
As previously noted, there are studies in the literature that have focused on 
barriers to effective care transitions and recommendations for improving transitions.  
Many of these studies have not focused on the assisted living setting.  In order to 
improve care transitions involving assisted living, an understanding of this unique 
setting is needed, including knowledge of the characteristics and regulations. 
 
a.  What are Assisted Living Facilities? 
Assisted living facilities (ALFs) are congregate “residential settings that provide 
or coordinate personal and health care services, 24-hour supervision, and assistance 
for the care of four or more adults who are aged, infirm, or disabled,” according to the 
Virginia Department of Social Services.34,35  ALFs are not nursing homes and they are a 
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non-medical setting.34  ALFs are also not the same as independent living.  The goal of 
ALFs is to help older adults maintain independence as long as possible.  ALFs may 
range in size from large houses to apartment buildings. 
The differences between ALFs and nursing facilities involve activities of daily 
living (ADLs) and instrumental activities of daily living (IADLs).  ADLs are basic tasks of 
everyday life and include eating, bathing, dressing, toileting, and transferring.36  IADLs 
are more complex activities including handling personal finances, cooking, shopping, 
traveling, doing housework, using the telephone, and taking medications.36   
The Virginia Department of Medical Assistance Services specifies differences 
between assisted living and nursing facilities.  Two levels of care in ALFs are indicated 
as residential living level of care in an ALF and regular assisted living level of care in an 
ALF.37  Residential living is the basic level of care and to qualify, individuals must be 
rated dependent in only one of seven ADLs; or rated dependent in one or more of four 
selected IADLs; or rated dependent in medication administration.37  To qualify for 
regular assisted living level of care, an individual must be rated dependent in two or 
more of seven ADLs; or rated dependent in behavior pattern.37  Medicaid only pays for 
regular assisted living, not residential living level of care in an ALF.37   
In contrast, to qualify for a nursing facility, an individual must meet at least one of 
the following three categories (meeting all elements within the category) and must have 
medical nursing needs.37  An individual has medical nursing needs if the individual’s 
medical condition requires observation and assessment to assure evaluation of needs 
due to an inability for self-observation or evaluation; or the individual has complex 
medical conditions that may be unstable or have the potential for instability; or the 
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individual requires at least one ongoing medical or nursing service.37  The three 
categories are:  Category 1 – rated dependent in two to four ADLs; and rated semi-
dependent or dependent in behavior pattern and orientation; and rated semi-dependent 
in joint motion or semi-dependent in medication administration; Category 2 – rated 
dependent in five to seven ADLs; and rated dependent in mobility; and Category 3 – 
rated semi-dependent in two to seven ADLs; and rated dependent in behavior and 
orientation.37 
 
b.  Regulations 
ALFs are regulated by the state in which the facility is located.  Direct care staff in 
ALFs are certified nurse aides, nursing assistants, geriatric assistants, or home health 
aides, or have completed an approved 40-hour direct care staff training.35  For facilities 
licensed for both residential and assisted living care, all direct care staff are required to 
have at least 16 hours of training relevant to the population in care annually.35  The 16 
hours of training is in addition to required first aid training, CPR training (if taken), and 
for medication aides, continuing education required by the Virginia Board of Nursing.35  
Individuals cannot live in an ALF if they have certain needs, such as dependent on a 
ventilator; require intravenous therapy or injections directly into the vein; have an 
airborne infectious disease that requires isolation; take psychotropic medications 
without appropriate diagnosis and treatment plans; nasogastric tubes; or require 
continuous licensed nursing care.35   
Personal assistance and care are provided to each resident of an ALF as needed 
including activities of daily living; instrumental activities of daily living; ambulation; 
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hygiene and grooming; and functions or tasks such as shopping, transportation, and 
correspondence.35  An individualized service plan is created to maximize the resident’s 
level of functional ability and should be filed in the resident’s record and a copy should 
be accessible at all times to direct care staff.  The individualized service plan should be 
completed within 72 hours of admission for each resident that is not capable of 
maintaining themselves in an independent living status.35  Outcomes should be noted 
on the plan or a separate document as progress is made.  The individualized service 
plan must be reviewed and updated at least once every 12 months and as needed as 
the resident’s condition changes.35   
Medication management is provided at ALFs.  The facility should manage 
medications for residents appropriately and have a written plan for doing so.35  The ALF 
should have a method for verifying medication orders are accurately transcribed on the 
medication administration record (MAR) and no medication, dietary supplement, diet, 
medical procedure or treatment can be started, changed, or discontinued without a valid 
order from a prescriber.35  Medications include prescription, over-the-counter, and 
sample medications.  It is particularly important to note that “whenever a resident is 
admitted to a hospital for treatment of any condition, the facility shall obtain new orders 
for all medications and treatments prior to or at the time of the resident's return to the 
facility.”35  The ALF also has the responsibility to be sure the primary physician is aware 
of all medication orders.35  Additionally, “a licensed health care professional, acting 
within the scope of the requirements of his profession, shall perform a review every six 
months of all the medications of the resident.”35  It is important to note that some ALFs 
have an on-site pharmacy while others do not. 
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It is important that health care professionals involved in the care of ALF residents 
are educated on these regulations.  A lack of knowledge may lead to health issues for 
the resident, such as medication-related problems and poor coordination of care at care 
transitions.  Obtaining an understanding of this setting and the residents of assisted 
living is important in order to provide the best care to the patient during interactions with 
the health care system and transitions in care. 
 
c.  Demographics 
The average cost for assisted living in Virginia is $43,650 annually, compared to 
nursing homes that cost $66,100 annually.38  Part time care is available at an annual 
cost of $14,100 for day care providers.38  There are 994,359 older adults living in 
Virginia.38  There are 6,315 professionally managed assisted living communities 
nationwide with approximately 475,500 apartments.39  The average resident of an ALF 
in the United States is an 87 year old female widow requiring help with two or more 
activities of daily living.39  Medication management has been identified as the most 
common reason for an older adult to move into an ALF and it is associated with quality 
of life and quality of care.40  Estimates of the number of daily medications taken by ALF 
residents range from 3.8 to 6.2.40 
According to Martin, ALFs and nursing facilities are comparable in terms of 
percentages of residents age 85 and older, Caucasian, and female.41  There are several 
differences between these settings.  It was reported that 83% of nursing facility 
residents were impaired in at least one ADL, which compares to 26% of assisted living 
residents.41  Moderate-to-severe dementia was reported in 51% of nursing facility 
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residents and 33% of assisted living residents.41  Behavior problems were indicated in 
30% of nursing facility residents and 42% of assisted living residents.41  Interestingly, 
the medication use in terms of routine medications, antidepressants, antipsychotics, and 
anxiolytics were similar in the two settings.41  
Of Medicare enrollees age 65 and older, 12% had limitations in IADLs only; 18% 
had limitations in one to two ADLs; 5% had limitations in three to four ADLs; 3% had 
limitations in five to six ADLs; and 4% were in a LTC facility, according to data from 
2009.42  Approximately 3% of Medicare enrollees age 65 and older resided in 
community housing with at least one service available and 4% resided in LTC facilities 
in 2009.42  The percentage of people residing in community housing with services and in 
LTC facilities increased with age.42  Among those residing in community housing with 
services, 48% reported access to help with medications.42  A greater number of 
functional limitations were noted for residents of LTC facilities than individuals in 
community housing with services, which were more than the functional limitations of 
traditional community residents.42  In fact, 51% of individuals in community housing with 
services had a limitation in at least one ADL, which compares to 26% of traditional 
community residents and 84% of LTC residents.42  
Impairment and medication management are important issues for LTC residents.  
There are specific characteristics of the ALF setting that may complicate transitions and 
increase vulnerability of residents.  ALFs contain elements of independence similar to 
community-dwelling situations, but residents of ALFs are more dependent in IADLs.  
ALFs are less regulated and lack the medical support of a nursing facility.  The 
functional and cognitive status of residents, lack of medically trained staff, increased 
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opportunity for miscommunication, and regulatory requirements create challenges 
during care transitions to ALFs.  Furthermore, the medical team is not on site and may 
not function as an interprofessional team.   
 
 
III.  Medication-Related Problems 
 
Provided the vulnerability of assisted living residents, medication-related 
problems in this setting should be identified and addressed in order to provide proper 
care to the resident.  Consequently, the classification and effects of medication-related 
problems will be discussed.  Pharmaceutical care will also be addressed as it applies to 
medication-related problems. 
 
a.  Classification 
The purpose of pharmacotherapy is to treat conditions and improve the well-
being of the patient.  As stated in the literature, the purpose of administering 
medications is to achieve cure of a disease, reduce or eliminate symptoms, slow the 
progression of a disease, and/or prevent a disease.43,44  However, medications are a 
double-edge sword, as positive and negative effects can occur.  Therefore the risk of 
diminishing the patient’s quality of life is a very real threat.  Negative outcomes may 
result from inappropriate prescribing, inappropriate delivery, inappropriate behavior by 
the patient (such as noncompliance), patient idiosyncrasies, and/or inappropriate 
monitoring.43   
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Medication-related problems can compromise the intended benefits of the 
treatment.  Although there are a number of variations of the definition, most include 
common components.  A medication-related problem (MRP) has been defined as “an 
event or circumstance involving medication therapy that actually or potentially interferes 
with an optimum outcome for a specific patient.”44,45  In addition, some classification 
systems include “preventable” in the definition.  As van Mil et al. point out, classifying 
MRPs is important for the development of pharmacy practice as well as research 
focused on pharmaceutical care.45   
There have been a number of attempts to create a classification of medication-
related problems, but no standard set of categories has been adopted.  There are 
different designations for the categories depending on the classification system and the 
approach to developing the classification may vary.  The cause of the MRP may be 
separated from the problem; the problem may describe the cause; and some may 
include a coding system for interventions.45  Additionally, the focus of the classification 
system may vary with regards to perspective. 
One example is a classification system developed by Strand et al., which 
involves eight categories including untreated indications, improper drug selection, 
subtherapeutic dosage, failure to receive drugs, overdosage, adverse drug reactions, 
drug interactions, and drug use without indication.43  Untreated indications are defined 
as medical conditions that require medication, but the patient is not receiving a 
medication for the indication.  Improper drug selection is defined by a patient taking a 
medication for an indication, but is taking the wrong drug.  A medical condition treated 
with too little of the correct drug describes the subtherapeutic dosage category.  If the 
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patient has a medical condition as a result of not receiving a drug, it is in the failure to 
receive drugs category and includes pharmaceutical, psychological, sociological, and 
economic reasons for not receiving the medication.  Overdosage involves treating 
medical problem with too much of the correct drug.  Adverse drug reactions include the 
patient experiencing a medical problem as a result of an adverse drug reaction or 
adverse effect.  If the patient is taking a drug for no medically valid indication, it is 
included in the drug use without indication category.43  In this classification system, 
problems and causes are not separated, as van Mil et al. point out.45  This is the list of 
categories the American Society of Health-System Pharmacists includes in their 
statement on pharmaceutical care in 1993, as well as the list mentioned on the 
American Society of Consultant Pharmacists website.44,46 
Additionally, medication regimens should be screened for appropriateness based 
on consideration for individual patient characteristics.  Tools have been developed that 
can be applied to aid in this screening process.  For example, the Beers criteria was 
developed by a consensus panel of experts to identify potentially inappropriate 
medication use in adults 65 years and older in the United States.47  A systems-defined 
medicine review tool, known as the Screening Tool of Older Persons’ potentially 
inappropriate Prescriptions (STOPP), was developed by geriatric pharmacotherapy 
specialists by a Delphi consensus method.48  Each of these tools are standard 
approaches and well-established criteria for identifying potentially inappropriate 
medications (PIMs). 
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b.  Effect 
MRPs can lead to a decrease in physical and mental function, and therefore, a 
decrease in self-care abilities and quality of life.46  The economic consequences are 
also concerning.  Older adults are more susceptible to MRPs and the degree of severity 
may also be worse in this population.   
Hanlon et al. published a literature review concerning medication-related 
problems, which provided insight regarding medication use in the older adult population.  
Approximately 5% of patients had one or more adverse drug events within the previous 
year and approximately 20% used one or more inappropriate medications, as 
determined by studies of ambulatory older adults.49  The most common medication-
related problems identified were drug-disease interactions and duration of use.49  
Sixteen percent of older adults in assisted living facilities used one or more 
inappropriate medications.49  A prospective case series identified MRPs in home care 
patients and found 39% of the 380 charts reviewed required pharmacist intervention.50  
Of the 232 MRPs identified, 28% were suboptimal therapy and 24% were the use of 
unnecessary medications.50  The majority of recommendations were discontinuing a 
medication (38.6%) and consulting the prescriber (23.2%).50   
 
c.  Pharmaceutical Care 
According to the American Society of Health-System Pharmacists, it is the 
pharmacist’s mission to provide pharmaceutical care.44  “Pharmaceutical care is the 
direct, responsible provision of medication-related care for the purpose of achieving 
definite outcomes that improve a patient’s quality of life.”44  The major functions of 
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pharmaceutical care involve identification, prevention, and resolution of MRPs.44,45  
Consequently, pharmacists should take the responsibility of addressing MRPs in order 
to provide the best care possible to patients regardless of practice setting.  It is 
important to note that this does not diminish the responsibility of other health care 
professionals; rather a collaborative approach should be utilized and continuity of care 
should be maintained.  Overall, improvements should be made to avoid MRPs resulting 
from low health literacy; lack of education for the patient, caregiver, and provider; and 
medication information tracking challenges.46  One approach to decreasing MRPs is the 
process of medication reconciliation. 
 
 
IV.  Medication Reconciliation 
 
Medication reconciliation involves a systematic and comprehensive review of a 
patient’s medication regimen at transitions in care.  The goal of medication 
reconciliation is to avoid inconsistencies, adverse effects, and duplicate or unnecessary 
medications.51  The importance of proper medication reconciliation in transitional care is 
brought to light when considering medication changes are common during transfers and 
are a cause of adverse drug events.2  Approximately half of adults experience a medical 
error after hospital discharge, and 19%-23% experience an adverse event, which is 
most commonly related to medications.52  Medication errors and adverse events caused 
by a lack of proper medication reconciliation at transitions in care impact patient welfare 
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and cause a financial burden.53  These facts underscore the importance of proper 
medication reconciliation in achieving safe care transitions. 
 
 
V.  Gap in Literature 
 
There is a lack of information in the literature regarding transitions in care 
involving assisted living.  Before an appropriate model can be developed to improve 
care transitions involving assisted living, we must first understand the type of problems 
related to medication use that occur and the barriers to effective transitions. 
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CHAPTER 2 
Significance and Specific Aims 
 
 
Multiple chronic conditions impact approximately half of older adults in the United 
States.15  Quality of life, functionality, and survival rates decrease as a result of age-
related changes coupled with multiple medical conditions and the concurrent use of 
multiple medications.  It has been determined that a positive linear relationship exists 
between the number of medication-related problems and the number of medications 
used.54  An increase in the number of health conditions can lead to usage of an 
expanded network of providers and can result in a lack of continuity of care. 
Hospital readmission within 30 days of discharge has been observed for almost 
one in five Medicare patients.18  A study by Coleman et al. aimed to describe patterns of 
post-hospital care transitions.55  The Medicare Current Beneficiary Survey was used to 
identify patients 65 years and older who were discharged from an acute care hospital.  
Results found that 61.2% of the beneficiaries experienced a single transfer; 17.9% 
experienced two transfers; 8.5% experienced three transfers; and 4.3% experienced 
four or more transfers.55  Coleman et al. indicated 13.4% to 25.0% of the post-hospital 
care patterns were complicated, meaning one or more transfers from lower- to higher-
intensity care environments.55  This raises concern for patient safety and cost.  It is 
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important to recognize that the potential for errors increases with an increase in care 
transitions.55   
It has been noted that almost 67% of adverse events following discharge are 
medication related, 29% of which are serious or life threatening and may lead to 
emergency department use and unscheduled hospital admissions.30  It has been 
determined that up to 60% of adverse drug events are preventable.30  The Institute of 
Medicine has stressed the importance of improving the health of older adults and 
decreasing costs by referring to it as a national priority.15 
It is important to recognize that pharmacist-specific interventions can lead to the 
identification and resolution of medication discrepancies, a decrease in the number of 
preventable adverse drug events following discharge, and a reduction in the amount of 
return visits to the emergency department.30  The cost of care to the health system has 
been estimated to increase by $3.8 million annually because of preventable adverse 
drug events that result in hospital readmissions.30  Medication reconciliation conducted 
by pharmacy students found that nearly half of patients admitted to an emergency 
department had at least one medication missing from medication lists recorded at 
triage.30 
There is lack of literature specifically focused on ALFs in terms of care transitions 
and medication-related problems.  It has been noted that inappropriate prescribing is 
common among assisted living residents.49  Since ALFs are state regulated, it is difficult 
to generalize results from studies in this setting.  Nonetheless, it is important to 
investigate the state of care transitions and medication-related problems in this setting. 
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The specific aims of this study are: 
1. To summarize demographic information for residents/patients who experienced 
one or more transitions to a 200-bed assisted living facility located in Virginia 
from their home, hospital, or a nursing home over a three month period. 
2. To describe and classify medication-related problems (MRPs) experienced by 
patients during transitions to a 200-bed assisted living facility located in Virginia 
from their home, hospital, or a nursing home over a three month period. 
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CHAPTER 3 
Aims 1 and 2 
 
 
I.  Methods 
 
A retrospective medical and pharmacy record review was conducted to address 
the aims of this project.  Approval for this study was obtained from the Virginia 
Commonwealth University Institutional Review Board as it qualified for exemption.  Data 
was collected from existing medical and pharmacy records at a long-term care 
pharmacy in Virginia for patients who transitioned to the approximately 200-bed 
assisted living facility from home, hospital, or nursing home between January 1, 2011 
and March 31, 2011.  This includes new admissions to assisted living from any setting 
or readmissions after hospitalization or nursing home stay.  The residents of this 
assisted living facility are primarily Caucasian and female with an average age of 86 
years. 
Data was collected from paper documents at the pharmacy including 
prescriptions, medication lists, and notes from the pharmacist documented at the time of 
the transition for cases of medication reconciliation problems.  Demographic data for 
each patient and transition were recorded including age, sex, type of institution from 
which patient transitioned, length of stay at institution, and reason for transition.  
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Medication regimen information was recorded (drug name, indication, strength, 
frequency, and directions) prior to the transition, upon admission to the assisted living 
facility, and a final list after medication reconciliation by the pharmacist.  MRPs, who 
identified the MRPs, and the resolution of the MRP were recorded.  The Strand et al. 
classification was modified for this study, as described in Table 1.43  MRPs were 
categorized as:  1) PIM:  potentially inappropriate medication utilization for specific 
patient characteristics based on the Beers47 and STOPP48 criteria for medication lists 
prior to the transition, upon admission to the assisted living facility, and after medication 
reconciliation by the pharmacist; 2) OU:  overuse, including drug dose too high, drug 
with no medically valid indication, or therapeutic duplication; 3) UU:  underuse, including 
drug dose too low or additional drug therapy needed; 4) DDI:  any type of drug 
interaction detected (not screened); 5) ADE:  adverse drug event or drug allergy 
(detected, not screened); 6) NA:  non-adherence to prescribed therapy or drug therapy 
inaccessible; or 7) NI:  no indication recorded (an indication must be documented on the 
order as required for administration of all prescription and over-the-counter medications 
and dietary supplements for assisted living residents in Virginia).  Any MRPs that could 
not be easily categorized were labeled as miscellaneous (MISC) and described 
qualitatively after consulting with the pharmacist for further details.   
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Table 1.  Classification of MRPs and Comparison to Strand et al. Classification 
Classification Used Comparison Strand et al. Classification43   
PIM:  potentially inappropriate 
medication utilization for 
specific patient characteristics 
based on the Beers47 and 
STOPP48 criteria 
 
PIMs are defined by 
Beers and STOPP 
criteria in this study. 
Improper Drug Selection:  
patient has a drug 
indication, but is taking the 
wrong drug 
 
OU:  overuse, including drug 
dose too high, drug with no 
medically valid indication, or 
therapeutic duplication 
Drug Use without 
Indication and 
Overdosage were both 
classified as OU. 
 
Drug Use without 
Indication:  patient is 
taking a drug for no 
medically valid indication 
Overdosage:  treating 
medical problem with too 
much of the correct drug 
 
UU:  underuse, including drug 
dose too low or additional drug 
therapy needed 
Untreated Indications 
and Subtherapeutic 
Dosage were both 
classified as UU 
Untreated Indications:  
medical problem that 
requires drug therapy, but 
the patient is not receiving 
a drug for the indication 
Subtherapeutic Dosage:  
medical problem treated 
with too little of the correct 
drug  
 
DDI:  drug interaction  Drug Interactions:  
medical problem as a result 
of a drug-drug, drug-food, 
or drug-laboratory 
interaction 
 
ADE:  adverse drug event or 
drug allergy 
 Adverse Drug Reactions:  
medical problem as a result 
of an ADR or adverse effect 
 
NA:  non-adherence to 
prescribed therapy or drug 
therapy inaccessible 
 Failure To Receive Drugs:  
medical problem as a result 
of not receiving a drug (for 
pharmaceutical, 
psychological, sociological, 
and economic reasons) 
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Classification Used Comparison Strand et al. Classification43   
NI:  no indication recorded  
 
Category added due to 
requirements in Virginia 
ALFs 
 
 
MISC:  Any MRPs that could 
not be easily categorized were 
labeled as miscellaneous and 
described qualitatively  
This category was 
added for any MRPs 
other than the above 
categories 
 
 
The data was entered into Microsoft® Excel spreadsheets from the paper 
documents by a team of four Doctor of Pharmacy students.  Consultation with the on-
site pharmacist occurred as needed for clarification and additional information regarding 
the documents.  After collection, the team reviewed the data and classified MRPs 
together until a consensus was reached.  The number of MRPs for each transition was 
calculated.  Patient demographics and MRPs were summarized using descriptive 
statistics.  MRPs classified as miscellaneous were then examined further to provide 
more detailed categorization using the notes collected in the data collection process. 
Data analysis was performed at Virginia Commonwealth University School of 
Pharmacy.  The data was stored using RDataStorage to keep the information secure.  
Only research personnel had access to the data.   
 
 
II.  Results 
 
A total of 45 patients (71.1% female) experienced a total of 59 transitions.  It was 
found that 26.7% of patients who transitioned during the three month period 
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experienced more than one transition.  The highest number of transitions for a single 
patient during this time period was three transitions.  At the time of the first transition, 
the average age of the patients was 85.6 years (range of 56 to 101 years).  The median 
length of stay away from the assisted living facility for those transitioning from a facility 
was three days (range 1 to 180 days).  The length of stay did not include patients 
transitioning from home to the assisted living facility.  The median length of stay in the 
emergency department was one day (range 1 to 7 days) and in the hospital was three 
days (range 1 to 15 days), compared to 30 days in the nursing home (range 7 to 180 
days).  Table 2 presents the study demographics.  There was an average of 18.3 pre-
transition medications (range 6 to 29 pre-transition medications), 12.5 medications 
(range 0 to 29 medications) in the discharge orders and/or upon admission to the ALF 
(post-transition medication list), and 15.9 medications (range 1 to 32 medications) 
following reconciliation by the pharmacist (final medication list).   
 
Table 2.  Demographics for Patients Transitioning to Assisted Living  
 
Total Number of Patients 45 
Number (Percent) of Males 13 (28.9%) 
Number (Percent) of Females 32 (71.1%) 
Average Age of Patients (at time of first transition) 85.6 years 
Age Range 56 to 101 years 
Total Number of Transitions 59 
Number of Patients with 1 Transition 33 
Number of Patients with 2 Transitions 10 
Number of Patients with 3 Transitions 2 
Average Number of Transitions Per Patient 1.3 
Median Length of Stay in Institution 3 days 
Length of Stay Range 1 to 180 days 
Total Number of Medications in Pre-Transition Medication List 678 
Total Number of Medications in Post-Transition Medication List 736 
Total Number of Medications in Final Medication List 
 
941 
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A total of 979 MRPs were identified, not including PIMs.  The most common MRP 
identified was no indication documented on the order, followed by underuse, overuse, 
and non-adherence (excluding miscellaneous MRPs and PIMs).  As previously 
mentioned, a recorded indication is required on each order for all prescription and over-
the-counter medications and dietary supplements for assisted living residents in the 
Commonwealth of Virginia.  Figure 1 shows a graphical representation of the total 
number of MRPs by type.  It was found that there were a total of 478 prescriptions 
without an indication recorded and a total of 267 cases of underuse identified.  A total of 
171 PIMs were identified based on the total number of PIMs as defined by at least one 
of the three criteria (Beers criteria considering diagnoses or conditions, Beers criteria 
independent of diagnoses or conditions, and STOPP criteria) in the final medication list 
after medication reconciliation by the pharmacist.   
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Figure 1.  Total Number of MRPs by Type 
*The PIM total is based on the total number of PIMs as defined by at least one of the 
three criteria (Beers criteria considering diagnoses or conditions, Beers criteria 
independent of diagnoses or conditions, and STOPP criteria) in the final medication 
list after medication reconciliation by the pharmacist. 
 
 
 
Figure 2 shows the average number of MRPs per transition by type.  Per 
transition, there was an average of 8.1 prescriptions without an indication recorded.  
Additionally, there was an average of 4.5 cases of underuse per transition.  There was 
an average of 2.9 PIMs per transition based on the total number of PIMs as defined by 
at least one of the three criteria (Beers criteria considering diagnoses or conditions, 
Beers criteria independent of diagnoses or conditions, and STOPP criteria) in the final 
medication list after medication reconciliation by the pharmacist, divided by the total 
number of transitions. 
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Figure 2.  Average Number of MRPs per Transition by Type 
*The PIM average is based on the total number of PIMs as defined by at least 
one of the three criteria (Beers criteria considering diagnoses or conditions, 
Beers criteria independent of diagnoses or conditions, and STOPP criteria) in the 
final medication list after medication reconciliation by the pharmacist, divided by 
the total number of transitions. 
 
 
Miscellaneous MRPs were examined and further categorized into four groups:  
incomplete directions; outdated, incorrect, and/or incomplete medication lists; 
inconsistent and/or incorrect directions; and incorrect formulation.  Incomplete directions 
accounted for 90 (62.5%) of the miscellaneous MRPs in this study.  Outdated, incorrect, 
and/or incomplete medication lists accounted for 38 (26.4%) of the miscellaneous 
MRPs, while 14 (9.7%) of the miscellaneous MRPs were due to inconsistent and/or 
incorrect directions.  Also, there were two (1.4%) cases of incorrect formulations on the 
medication list.   
The three criteria used to identify PIMs were the Beers criteria considering 
diagnoses or conditions, Beers criteria independent of diagnoses or conditions, and 
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STOPP criteria.  Table 3 details the number of PIMs identified in each medication list 
(prior to the transition, upon admission to the ALF, and a final list after medication 
reconciliation by the pharmacist) by each of the three criteria.  The number of PIMs 
identified was higher after medication reconciliation using both the Beers and STOPP 
criteria to define PIMs.  Beers criteria independent of diagnoses or conditions indicated 
27 pre-transition PIMs, 30 post-transition PIMs, and 39 PIMs on the final medication list.  
Beers criteria considering diagnoses or conditions indicated 45 pre-transition PIMs, 39 
post-transition PIMs, and 56 PIMs on the final medication list.  The STOPP criteria 
indicated 83 pre-transition PIMs, 93 post-transition PIMs, and 113 PIMs on the final 
medication list. 
 
Table 3.  PIMs Identified 
Medication List Beers* Beers** STOPP 
Pre 27 45 83 
Post 30 39 93 
Final 39 56 113 
Total 96 140 289 
*Beers criteria independent of diagnoses or conditions 
**Beers criteria considering diagnoses or conditions 
 
As previously noted, there were 171 PIMs identified by at least one of the three 
criteria in the final medication list after medication reconciliation by the pharmacist.  Of 
these 171 PIMs, 115 (67.3%) were medications on the medication list prior to the 
transition.  Regarding “as needed” (PRN) medications, 61 (35.7%) of the 171 PIMs in 
the final medication list were PRN.  Additionally, 44 (25.7%) out of the 171 PIMs in the 
final medication list were added during the resolution of other MRPs.  The most 
common PIMs in the final medication list after medication reconciliation by the 
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pharmacist were identified to be aspirin, promethazine, tramadol, lorazepam, and 
amlodipine.  Each of these appeared in the list of PIMs in the final medication list 
between 10 and 18 times. 
The number of transitions and MRPs by setting are detailed in Table 4, with the 
exception of PIMs.  The majority of transitions to the ALF were from the emergency 
department (ED) and hospital.  Additionally, the total number of MRPs was found to be 
the highest in transitions from the hospital and emergency department.  The emergency 
department and hospital transitions also indicated the highest number of MRPs in these 
settings involved no indication recorded and underuse.  
 
Table 4.  Number of Transitions and MRPs by Setting 
Setting  Number of Transitions 
Total MRPs 
in Each 
Setting 
Types of MRPs 
OU UU DDI ADE NA NI MISC 
Assisted Living 3 37 0 0 0 0 16 17 4 
ED 17 327 11 145 1 0 3 129 38 
Home 8 55 2 0 0 0 1 30 22 
Hospital 16 432 32 88 0 0 7 242 63 
Nursing Home 12 121 12 33 0 1 4 59 12 
Not Documented 3 7 0 1 0 0 0 1 5 
Total 59 979 57 267 1 1 31 478 144 
 
The pharmacist and researcher identified the majority of the MRPs in this project.  
Table 5 shows the total number, and average number per transition, of MRPs identified 
by the pharmacist, researcher, home health, and a joint effort between the pharmacist 
and patient.  Not including PIMs, 71% of MRPs were identified by the pharmacist at the 
time of transition.  The PIMs were all identified by the researcher and these numbers 
are not included in Table 5.   
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Table 5.  Who Identified the MRPs* 
  Pharmacist Researcher 
Home 
Health 
Pharmacist and 
Patient 
Total 698 276 4 1 
Average Per Transition 11.83 4.68 0.068 0.017 
*Excludes PIMs, which were all identified by the researcher 
 
 
III.  Discussion 
 
MRPs were identified and classified for patients transitioning to an assisted living 
facility over a three month period.  It is interesting to note 979 MRPs, not including 
PIMs, were identified in this study and there were 941 total medications in the final list 
following medication reconciliation by the pharmacist.  In an effort to reduce the number 
of MRPs, interventions targeting the most common MRPs are warranted.  Additionally, 
given the number of PIMs identified in this study, consideration should be given to 
identifying and addressing PIMs at the time of medication reconciliation for every 
transition.   
Targeted education for the health care professional, patient, and caregiver may 
decrease MRPs, particularly the most common MRPs identified in this study.  Efforts to 
educate health care professionals should focus on those who practice in the hospital 
and emergency department settings because the highest number of transitions and 
MRPs were identified for transitions from these settings.  Educational efforts may 
include training regarding the appropriate ALF regulations, such as the need for new 
orders and an indication for each order for all assisted living residents in the 
Commonwealth of Virginia.  Additionally, it may be possible to include these 
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requirements in decision support systems in the electronic health record systems.  
Education regarding regulations may have an impact on the number of orders without a 
documented indication, as well as the amount of underuse found in this study.  Many 
residents returned to the ALF without prescriptions for their medications that needed to 
be continued based on their pre-transition medication list.  This may be due to a lack of 
awareness that the patient is an assisted living resident with the need for new orders for 
every medication the patient will take upon returning to the ALF.  The fast pace and 
intense responsibility of the acute care setting may also have an impact.  However, 
complying with the regulations in ALFs may decrease adverse events for the resident if 
the assisted living staff is informed regarding the resident’s condition and more time can 
be focused on optimizing the medication regimen.  Additionally, there is opportunity for 
education regarding appropriate prescribing for the older adult population, focusing on 
potentially inappropriate medications and preferred treatment choices for this 
population.  It is important to recognize education should also be provided to the patient 
and caregiver regarding the patient’s medical conditions, medications, how to 
appropriately take each medication, expectations, what to avoid, and what symptoms 
would warrant a call to the provider.  It would also be helpful to communicate 
information regarding the patient’s medical conditions, medications, and plan to the 
assisted living staff that will be providing care. 
The MRPs of DDI and ADE were detected, but not screened.  This may have 
underestimated the number of DDIs and ADEs that occurred because some may not 
have been reported.  Additionally, cases of NA were noted when a medication was not 
accessible to the patient or notification of non-adherence was provided.  NA may be 
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underestimated in terms of non-adherence.  Medication administration records may be 
useful in shedding light on the issue of non-adherence.  Further classification of MISC 
MRPs identified issues such as incomplete directions and inconsistent and/or incorrect 
directions, which may indicate a need for focused attention to detail when prescribing. 
Transitions involving emergency departments and hospitals resulted in the 
highest number of MRPs; therefore, these transitions should be a focus for future 
interventions.  Before an intervention can be proposed, an understanding of the current 
process is needed.  For example, when a resident transitions from the ALF in this study 
to an acute care setting, the intent is for a paper medication administration record to be 
sent with the resident.  The hope is the medication administration record ends up in the 
hands of the health care professional providing care to the patient.  The current study 
does not provide sufficient information to determine how often the current and correct 
medication list is available to the provider in the acute care setting.  However, the data 
from this study shows there are a number of patients who return to the ALF with 
outdated, incorrect, and/or incomplete medication lists.  This may indicate current 
medication administration records do not always land in the hands of the provider.  This 
highlights an opportunity for improved communication and consideration for electronic 
records shared between settings so the most updated information is available to all 
health care professionals involved in the patient’s care.  Utilization of information 
technology should be considered for future interventions to improve communication.  
The number of MRPs identified in this study suggests an emphasis is needed on 
medication reconciliation at each transition.  The quantity of MRPs surrounding care 
transitions may be decreased by designating qualified professionals at each setting as 
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the contact persons charged with ensuring that medication reconciliation occurs.  This 
should be done for each patient upon admission and prior to discharge.  On average, 
the pharmacist identified 11.83 MRPs per transition, excluding PIMs; this highlights the 
amount of effort the pharmacist focuses on medication reconciliation and transitional 
care in this setting.  The pharmacist identified the majority of the MRPs in this study; 
therefore, the pharmacist could provide valuable input regarding the development of 
interventions needed to reduce MRPs.  Pharmacists have the potential to decrease 
health care costs by addressing MRPs.  Future research investigating the cost of MRPs 
in the ALF setting is also needed.  
An interesting finding in this study was the number of PIMs identified was higher 
after medication reconciliation using both the Beers and STOPP criteria to define PIMs.  
This may be due to the pharmacist dealing with more urgent matters at the time of 
transition and medication reconciliation; consequently, the pharmacist may plan for 
PIMs to be addressed at the time of medication review rather than at the time of 
transition.  It may also be impacted by the fact that some of the post-transition 
medication lists were missing most of the patient’s medications because new orders 
were not written (as required by Virginia ALF regulations).  As previously mentioned, a 
number of the PIMs in the final medication list after medication reconciliation by the 
pharmacist were identified as PRN medications.  Others were medications on the 
medication list prior to the transition and some were added during the resolution of other 
MRPs.  These results indicate there are multiple possible reasons for the increase in 
PIMs after medication reconciliation.  It is also important to note some of the PIMs 
identified may be appropriate for the individual patient.  Criteria used to identify PIMs 
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should not replace clinical judgment.  An appropriate monitoring plan should also be 
implemented. 
It was found that the STOPP criteria identified a higher number of PIMs than 
each application of Beers criteria in this study.  This is consistent with previous studies 
in the literature.  One possible explanation is the STOPP was developed more recently 
than the Beers criteria applied in this study.  Again, criteria used to identify PIMs are not 
the final word on medication appropriateness, rather a screening tool to identify 
medications that may require additional evaluation prior to use in certain patients.  
Although medications are technically included in the Beers or STOPP criteria, valid use 
occurs in practice and may be appropriate for an individual patient; thus, clinical 
judgment should be utilized.  A comprehensive view of the patient’s needs, preferences, 
and medical conditions is necessary to appropriately evaluate and reconcile a patient’s 
medications. 
The lack of consensus regarding definitions of MRPs or the classification system 
for MRPs in the literature makes it difficult to compare results from various studies.  It 
would be helpful to have a clear, standard, accepted definition and classification system 
for MRPs.  This may help in the comparison of future studies in the literature, as well as 
to increase awareness of MRPs for both practitioners and researchers.   
A strength of this study is the data was collected and MRPs were categorized as 
a team; this strengthens the accuracy of the classifications as a consensus was 
reached.  This approach may also decrease errors in the data because the information 
was reviewed by more than one researcher.  Additionally, the researcher had access to 
the pharmacy staff, which improved the availability and accuracy of the information 
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obtained in this study.  Many assumptions were minimized with access to the 
pharmacist for clarification or verification of understanding the information provided in 
the medical and pharmacy records.  This study contributes to the small body of 
literature focused on care transitions involving assisted living. 
Several limitations should be acknowledged regarding this study.  It is possible 
that not all transitions were captured.  Transition information was obtained from the 
pharmacist for the three month period.  Additionally, since the total number of residents 
is unknown for this time period, the rate of transitions within the community cannot be 
calculated.  As is typical for the ALF setting, access to patient comorbidities, lab values, 
adverse drug events, and monitoring plans was inconsistent; therefore, the number of 
MRPs may be underestimated.  In most cases, the pharmacist was only provided with 
prescriptions and/or discharge orders.  It is important to note that the pharmacist was 
aware of the study purpose and time period, which may have influenced the results. 
An additional limitation is the STOPP and Beers criteria were applied to all 
patients in this study including the two patients who were less than 65 years of age.  
Furthermore, the STOPP and Beers criteria were not created specifically for the 
assisted living setting and the criteria may not be as appropriate for application in this 
setting.  The STOPP criteria was developed with a focus on the hospital setting.48  The 
2003 Beers criteria was updated for ambulatory and nursing facility populations and was 
developed using literature focused on medication use in community-dwelling older 
adults and older adults living in nursing homes, as well as a panel of experts selected to 
represent acute, long-term, and community practice settings.47  Given this information, 
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application of the Beers criteria to assisted living may be more appropriate than the 
application of the STOPP criteria. 
Also, this study was conducted in one ALF in Virginia; thus, the results may not 
be generalizable to other populations or facilities in other states as regulations vary by 
state.  Characteristics of ALFs can vary greatly even within the same state; therefore, it 
is difficult to generalize results and compare these results to other studies.  Studying an 
ALF without an on-site pharmacy may yield different results.  Given the wide variety of 
ways that pharmacy services are provided to ALFs and the variation in the pharmacist’s 
engagement (versus other facility staff), it may be difficult to generalize results to other 
ALFs in Virginia.  Additional studies in various settings would be needed in order to 
draw further conclusions regarding other long-term care facilities. 
Since the analysis of data for this study, an update to the Beers Criteria was 
completed and published;56 therefore, another limitation of this study is the use of the 
2003 Beers Criteria.  The 2012 Beers Criteria has been altered from 2003; it lacks 
medications that are no longer available and includes medications that have become 
available since 2003.  It also updates research and appropriate prescribing information.  
Future application of the 2012 Beers Criteria to this data is planned. 
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CHAPTER 4 
Conclusion 
 
 
MRPs arising during transitions of care to assisted living were identified; many of 
these are potentially preventable through effective care transitions and medication 
reconciliation.  A number of potential approaches for improvement were discussed.  
Past studies have demostrated that education has improved knowledge and confidence 
of providers and has had a positive impact on the patient care provided.  It is 
hypothesized that education provided to health care professionals, patients, and 
caregivers may improve care transitions involving assisted living.  Appropriate health 
care professionals should be tasked with medication reconciliation at each setting for 
each care transition.  A focus should be placed on improving communication between 
health care professionals, patients, caregivers, and settings.  A consensus definition for 
MRPs and classification system should be determined and utilized.  Additionally, the 
lack of information in the literature focused on assisted living care transitions should be 
addressed.  A future study to identify barriers to effective transitions in this setting and 
ways to improve these care transitions from the LTC perspective has been proposed.  
Once an understanding of the barriers to effective transitions is obtained, an 
intervention to improve care and reduce MRPs during transitions involving assisted 
living should be designed, evaluated, and ultimately implemented.  
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CHAPTER 5 
Proposed Next Step 
 
 
I.  Specific Aim 
 
The specific aim of this study is to identify barriers to effective transitions to 
assisted living facilities in Virginia, as well as possible ways to improve these transitions. 
 
 
II.  Methods 
 
Key informant interviews will be conducted with staff members involved in care 
transitions (e.g., pharmacy, nursing, marketing, and resident services personnel at two 
assisted living facilities in Virginia as well as staff at LTC pharmacies).  Both assisted 
living facilities with and without on-site pharmacy services will be included.   
Primary contacts at each assisted living facility will be informed about the study 
and asked which staff members should be approached for an interview at the facility.  
Initial contact will be made via a phone call from the researcher to ask if he/she is willing 
to be interviewed.  Staff members will be asked for their consent prior to the interview.   
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Interviewees will not be identified by individual name or facility name.  A general 
description of the facility and his/her role will be used rather than facility name or precise 
job title.  Appendix A includes the interview session information and questions.  
Interviews will be recorded to improve understanding of the responses.  However, 
recorded interviews will be transcribed and once the transcription is determined to be 
error free, the recording will be destroyed.  Responses to interview questions will be 
analyzed to identify themes. 
Data analysis will be performed at Virginia Commonwealth University School of 
Pharmacy.  The data will be stored using RDataStorage to keep the information secure.  
Only research personnel will have access to the data. 
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Appendix A 
 
 
Key Informant Interview Session 
 
The following questions will be asked of interviewees in addition to clarifying 
questions as needed.  Each interview length is estimated at approximately 30 minutes.  
Consent will be obtained prior to the interview.  Participation in this interview is voluntary 
and may be discontinued at any time.   
No personally identifiable information will be collected.  Interviewees will not be 
identified by individual name or facility name.  A general description of the facility and 
his/her role will be used rather than facility name or precise job title.  Any recorded 
interviews will be transcribed and once the transcription is determined to be error free, 
the tape will be destroyed.   
 
 
Interview Questions 
 
With regards to medication-related problems during transitions to assisted living: 
1. What are your job responsibilities with respect to care transitions and 
medications? 
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2. What is the current process for handling medications during a transition (moving 
into the assisted living facility versus returning from a nursing home or hospital)? 
3. Other than yourself, who else is involved in managing the transitions process? 
4. What do you see as the barriers to effective transitions? 
5. Are there examples you can share when transitions went well, and when they did 
not? 
6. What ideas do you have for improving transitions? 
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